Proteostasis Therapeutics Announces Management Changes and Appointments

Geoffrey S. Gilmartin, MD, MMSc, to Succeed Po-Shun Lee, MD as Chief Medical Officer; Dr. Lee to Remain a Consultant for the Company Andrey E. Belous, MD, PhD, Appointed as Senior Medical Director, Joining From Galapagos NV BOSTON, July 23, 2019 -- (... Biopharmaceuticals, Personnel Proteostasis Therapeutics, transmembrane conductance regulator, cystic fibrosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news